Patents by Inventor Mark A. Pecor

Mark A. Pecor has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7083643
    Abstract: This invention is directed to methods for treating aneurysms wherein the aneurysmal sac is filled with a non-particulate agent or plurality of such agents and/or with a fluid composition which solidifies in situ. Filling of the aneurysmal sac employs sufficient amount of the non-particulate agent or plurality of such agents and/or the fluid composition to inhibit blood flow into the aneurysm sac. In addition, the methods of this invention also provide for non-endogenous isolation of the parent artery proximal and distal to the aneurysmal sac from systemic blood flow of the treated mammal. The combination of these features provides for treatment of the aneurysmal sac while, at the same time, inhibiting aneurysm formation and/or regrowth in the diseased portions of the arterial wall proximal and distal to the treated aneurysm.
    Type: Grant
    Filed: March 17, 2003
    Date of Patent: August 1, 2006
    Assignee: Micro Therapeutics, Inc.
    Inventors: Thomas J. Whalen, II, Richard J. Greff, Kevin P. Gilmartin, Douglas Ray Hayman, Todd J. Hewitt, Ed L. Olson, Mark A. Pecor, Earl H. Slee, George Wallace
  • Publication number: 20030135264
    Abstract: This invention is directed to methods for treating aneurysms wherein the aneurysmal sac is filled with a non-particulate agent or plurality of such agents and/or with a fluid composition which solidifies in situ. Filling of the aneurysmal sac employs sufficient amount of the non-particulate agent or plurality of such agents and/or the fluid composition to inhibit blood flow into the aneurysm sac. In addition, the methods of this invention also provide for non-endogenous isolation of the parent artery proximal and distal to the aneurysmal sac from systemic blood flow of the treated mammal. The combination of these features provides for treatment of the aneurysmal sac while, at the same time, inhibiting aneurysm formation and/or regrowth in the diseased portions of the arterial wall proximal and distal to the treated aneurysm.
    Type: Application
    Filed: March 17, 2003
    Publication date: July 17, 2003
    Inventors: Thomas J. Whalen, Richard J. Greff, Kevin P. Gilmartin, Douglas Ray Hayman, Todd J. Hewitt, Ed L. Olson, Mark A. Pecor, Earl H. Slee, George Wallace
  • Patent number: 6569190
    Abstract: This invention is directed to methods for treating aneurysms wherein the aneurysmal sac is filled with a non-particulate agent or plurality of such agents and/or with a fluid composition which solidifies in situ. Filling of the aneurysmal sac employs sufficient amount of the non-particulate agent or plurality of such agents and/or the fluid composition to inhibit blood flow into the aneurysm sac. In addition, the methods of this invention also provide for non-endogenous isolation of the parent artery proximal and distal to the aneurysmal sac from systemic blood flow of the treated mammal. The combination of these features provides for treatment of the aneurysmal sac while, at the same time, inhibiting aneurysm formation and/or regrowth in the diseased portions of the arterial wall proximal and distal to the treated aneurysm.
    Type: Grant
    Filed: March 20, 2001
    Date of Patent: May 27, 2003
    Assignee: Micro Therapeutics, Inc.
    Inventors: Thomas J. Whalen, II, Richard J. Greff, Kevin P. Gilmartin, Douglas Ray Hayman, Todd J. Hewitt, Ed L. Olson, Mark A. Pecor, Earl H. Slee, George Wallace
  • Publication number: 20020168331
    Abstract: This invention is directed to methods for treating aneurysms wherein the aneurysmal sac is filled with a non-particulate agent or plurality of such agents and/or with a fluid composition which solidifies in situ. Filling of the aneurysmal sac employs sufficient amount of the non-particulate agent or plurality of such agents and/or the fluid composition to inhibit blood flow into the aneurysm sac. In addition, the methods of this invention also provide for non-endogenous isolation of the parent artery proximal and distal to the aneurysmal sac from systemic blood flow of the treated mammal. The combination of these features provides for treatment of the aneurysmal sac while, at the same time, inhibiting aneurysm formation and/or regrowth in the diseased portions of the arterial wall proximal and distal to the treated aneurysm.
    Type: Application
    Filed: March 20, 2001
    Publication date: November 14, 2002
    Inventors: Thomas J. Whalen, Richard J. Greff, Kevin P. Gilmartin, Douglas Ray Hayman, Todd J. Hewitt, Ed L. Olson, Mark A. Pecor, Earl H. Slee, George Wallace